New Law Opens the Door to More Personalized and Effective Treatment

New Law Opens the Door to More Personalized and Effective Treatment - Healthcare Law Update - June 2025 - Brach Eichler
BACK TO INSIGHTS     Articles

6/1/2025

Assembly Bill 4163, signed into law on April 23, 2025, requires health insurers to cover biomarker testing for the purposes of diagnosis, treatment, appropriate management, or ongoing monitoring of an individual’s disease or condition. Biomarker testing analyzes an individual’s biological indicators to provide insights into their health status or risk of certain diseases. Under the law, health insurers must cover the testing as long as it is supported by medical and scientific evidence. The legislation aims to eliminate uncertainty around insurance coverage and to reduce high out-of-pocket costs for such testing.

Click Here to read the entire June 2025 Healthcare Law Update now!

For more information, contact:
John D. Fanburg, Chair | 973.403.3107 | jfanburg@bracheichler.com
Edward Hilzenrath | 973.403.3114 | ehilzenrath@bracheichler.com
Rebecca T. Falk | 973.364.8393 | rfalk@bracheichler.com

*This is intended to provide general information, not legal advice. Please contact the authors if you need specific advice.

Related Practices:   Healthcare Law

Related Industry:   Healthcare